BIONDINI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.476
EU - Europa 346
AS - Asia 171
AF - Africa 1
OC - Oceania 1
Totale 2.995
Nazione #
US - Stati Uniti d'America 2.471
IT - Italia 198
CN - Cina 134
SE - Svezia 64
FI - Finlandia 40
IN - India 18
GB - Regno Unito 15
VN - Vietnam 14
DE - Germania 12
IE - Irlanda 12
CA - Canada 4
NL - Olanda 3
TR - Turchia 3
KR - Corea 2
CH - Svizzera 1
FR - Francia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SC - Seychelles 1
Totale 2.995
Città #
Fairfield 510
Ashburn 279
Woodbridge 273
Chandler 222
Houston 184
Seattle 173
Cambridge 169
Wilmington 128
Ann Arbor 103
Beijing 51
Padova 42
San Diego 41
Helsinki 35
Medford 35
Princeton 33
Roxbury 28
Des Moines 24
Trieste 18
Pune 16
Dong Ket 14
Dublin 12
Jinan 12
New York 11
Nanjing 10
Pordenone 9
Washington 8
London 7
Udine 6
Hebei 5
Nanchang 5
Ronchis 5
Shenyang 5
Cordenons 4
Cordovado 4
Falls Church 4
Lancenigo-Villorba 4
Maniago 4
Zion 4
Boardman 3
Breda di Piave 3
Guangzhou 3
Jiaxing 3
Kunming 3
Siracusa 3
Cagliari 2
Crotone 2
Galliera Veneta 2
Giresun 2
Goyang-si 2
Hangzhou 2
Hefei 2
Kilburn 2
Lestizza 2
Milan 2
Mississauga 2
Ponzano Veneto 2
Porcia 2
Redwood City 2
Taizhou 2
Tianjin 2
Zhengzhou 2
Andrano 1
Barletta 1
Bresso 1
Caguas 1
Casarsa della Delizia 1
Cavarzere 1
Changsha 1
Chiswick 1
Cornedo Vicentino 1
Dallas 1
Ferentino 1
Frankfurt am Main 1
Fuzhou 1
Genzano Di Roma 1
Grafing 1
Gurgaon 1
Haikou 1
Hounslow 1
Istanbul 1
Lappeenranta 1
Las Vegas 1
Legnaro 1
Mahbubnagar 1
Mahé 1
Mortegliano 1
Mugnano Di Napoli 1
New Bedfont 1
New Orleans 1
Ningbo 1
Philadelphia 1
Piano Di Sorrento 1
Pinehaven 1
Sacile 1
San Daniele del Friuli 1
San Donà di Piave 1
Selvazzano Dentro 1
Siena 1
Taiyuan 1
Toronto 1
Totale 2.588
Nome #
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 171
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 138
From cigarette smoking to Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis. Why? 137
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 133
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 131
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 119
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 118
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 116
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 115
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 104
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 100
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 96
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 91
Successful lung retransplantation in a patient with acute fibrinous and organizing pneumonia: A case report 90
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies 82
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 81
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 78
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 76
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 73
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 73
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 68
Idiopathic pulmonary fibrosis and lung transplantation: When it is feasible 67
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 65
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 64
Risk Factors for Development and Severity of COVID-19 in COPD Patients 63
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 60
Herpes simplex virus 2 hepatitis in a lung transplant recipient: A diagnostic challenge 60
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 59
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 56
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 52
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey 49
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment 48
Pulmonary fibrosis secondary to COVID-19: a call to arms? 46
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment 43
Exome sequencing in diseased and healthy subjects with alpha-1 antitrypsin deficiency 42
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 24
The role of bronchoscopy in the diagnosis and management of patients with sars-cov-2 infection 24
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients 19
Symptomatic smokers without COPD have physiological changes heralding the development of COPD 17
Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD? 15
Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters? 10
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 7
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF) 6
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison? 3
Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities 3
Editorial: New insights in sarcoidosis: from bench to bedside 1
Totale 3.093
Categoria #
all - tutte 11.194
article - articoli 10.032
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201976 0 0 0 0 0 0 0 0 2 17 33 24
2019/2020725 22 7 20 167 93 46 64 78 92 75 43 18
2020/2021693 23 35 49 45 26 28 93 46 88 124 89 47
2021/2022635 23 26 112 46 68 34 18 90 76 11 27 104
2022/2023489 84 33 23 48 84 49 10 42 76 7 27 6
2023/2024323 10 52 49 29 40 86 26 31 0 0 0 0
Totale 3.093